<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;ff=20241115111347&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;ff=20241115111347&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Fri, 15 Nov 2024 16:13:47 +0000</lastbuilddate>
<pubDate>Thu, 14 Nov 2024 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Improving English proficiency for scientific communication by non-fluent speakers</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39543309/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Nov 14. doi: 10.1038/s41569-024-01102-1. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39543309/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39543309</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01102-1>10.1038/s41569-024-01102-1</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39543309</guid>
<pubDate>Thu, 14 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Dong Zhao</dc:creator>
<dc:creator>Maria Rubini</dc:creator>
<dc:date>2024-11-14</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Improving English proficiency for scientific communication by non-fluent speakers</dc:title>
<dc:identifier>pmid:39543309</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01102-1</dc:identifier>
</item>
<item>
<title>Trade-offs between vessel-based and substrate-based nomenclatures for coronary heart diseases</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39543308/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Nov 14. doi: 10.1038/s41569-024-01099-7. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39543308/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39543308</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01099-7>10.1038/s41569-024-01099-7</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39543308</guid>
<pubDate>Thu, 14 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Robert A Byrne</dc:creator>
<dc:creator>Adnan Kastrati</dc:creator>
<dc:date>2024-11-14</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Trade-offs between vessel-based and substrate-based nomenclatures for coronary heart diseases</dc:title>
<dc:identifier>pmid:39543308</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01099-7</dc:identifier>
</item>
<item>
<title>Monocytes migrate to the brain after MI to promote deep sleep to aid cardiac healing</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39543307/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Nov 14. doi: 10.1038/s41569-024-01106-x. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39543307/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39543307</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01106-x>10.1038/s41569-024-01106-x</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39543307</guid>
<pubDate>Thu, 14 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Irene Fernández-Ruiz</dc:creator>
<dc:date>2024-11-14</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Monocytes migrate to the brain after MI to promote deep sleep to aid cardiac healing</dc:title>
<dc:identifier>pmid:39543307</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01106-x</dc:identifier>
</item>
<item>
<title>Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associations</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39541968/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>The microbiota in individual habitats differ in both relative composition and absolute abundance. While sequencing approaches determine the relative abundances of taxa and genes, they do not provide information on their absolute abundances. Here, we developed a machine-learning approach to predict fecal microbial loads (microbial cells per gram) solely from relative abundance data. Applying our prediction model to a large-scale metagenomic dataset (n = 34,539), we demonstrated that microbial...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Nov 4:S0092-8674(24)01204-2. doi: 10.1016/j.cell.2024.10.022. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The microbiota in individual habitats differ in both relative composition and absolute abundance. While sequencing approaches determine the relative abundances of taxa and genes, they do not provide information on their absolute abundances. Here, we developed a machine-learning approach to predict fecal microbial loads (microbial cells per gram) solely from relative abundance data. Applying our prediction model to a large-scale metagenomic dataset (n = 34,539), we demonstrated that microbial load is the major determinant of gut microbiome variation and is associated with numerous host factors, including age, diet, and medication. We further found that for several diseases, changes in microbial load, rather than the disease condition itself, more strongly explained alterations in patients' gut microbiome. Adjusting for this effect substantially reduced the statistical significance of the majority of disease-associated species. Our analysis reveals that the fecal microbial load is a major confounder in microbiome studies, highlighting its importance for understanding microbiome variation in health and disease.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39541968/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39541968</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.10.022>10.1016/j.cell.2024.10.022</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39541968</guid>
<pubDate>Thu, 14 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Suguru Nishijima</dc:creator>
<dc:creator>Evelina Stankevic</dc:creator>
<dc:creator>Oliver Aasmets</dc:creator>
<dc:creator>Thomas S B Schmidt</dc:creator>
<dc:creator>Naoyoshi Nagata</dc:creator>
<dc:creator>Marisa Isabell Keller</dc:creator>
<dc:creator>Pamela Ferretti</dc:creator>
<dc:creator>Helene Bæk Juel</dc:creator>
<dc:creator>Anthony Fullam</dc:creator>
<dc:creator>Shahriyar Mahdi Robbani</dc:creator>
<dc:creator>Christian Schudoma</dc:creator>
<dc:creator>Johanne Kragh Hansen</dc:creator>
<dc:creator>Louise Aas Holm</dc:creator>
<dc:creator>Mads Israelsen</dc:creator>
<dc:creator>Robert Schierwagen</dc:creator>
<dc:creator>Nikolaj Torp</dc:creator>
<dc:creator>Anja Telzerow</dc:creator>
<dc:creator>Rajna Hercog</dc:creator>
<dc:creator>Stefanie Kandels</dc:creator>
<dc:creator>Diënty H M Hazenbrink</dc:creator>
<dc:creator>Manimozhiyan Arumugam</dc:creator>
<dc:creator>Flemming Bendtsen</dc:creator>
<dc:creator>Charlotte Brøns</dc:creator>
<dc:creator>Cilius Esmann Fonvig</dc:creator>
<dc:creator>Jens-Christian Holm</dc:creator>
<dc:creator>Trine Nielsen</dc:creator>
<dc:creator>Julie Steen Pedersen</dc:creator>
<dc:creator>Maja Sofie Thiele</dc:creator>
<dc:creator>Jonel Trebicka</dc:creator>
<dc:creator>Elin Org</dc:creator>
<dc:creator>Aleksander Krag</dc:creator>
<dc:creator>Torben Hansen</dc:creator>
<dc:creator>Michael Kuhn</dc:creator>
<dc:creator>Peer Bork</dc:creator>
<dc:creator>GALAXY and MicrobLiver Consortia</dc:creator>
<dc:date>2024-11-14</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associations</dc:title>
<dc:identifier>pmid:39541968</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.10.022</dc:identifier>
</item>
<item>
<title>Coronary air embolism causing myocardial infarction following a blunt chest trauma</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39540942/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Nov 14:ehae771. doi: 10.1093/eurheartj/ehae771. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39540942/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39540942</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae771>10.1093/eurheartj/ehae771</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39540942</guid>
<pubDate>Thu, 14 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Elise Bendriss</dc:creator>
<dc:creator>Jean Pasqueron</dc:creator>
<dc:creator>Jean Bardon</dc:creator>
<dc:date>2024-11-14</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Coronary air embolism causing myocardial infarction following a blunt chest trauma</dc:title>
<dc:identifier>pmid:39540942</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae771</dc:identifier>
</item>
<item>
<title>A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39540306/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Measurement of targeted protein biomarkers produced superior prediction of aggregated and disaggregated cardiovascular events. This study represents an important proof of concept for the application of targeted proteomics in predicting a range of cardiovascular outcomes.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Nov 14. doi: 10.1161/CIRCULATIONAHA.124.070454. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Many studies have explored whether individual plasma protein biomarkers improve cardiovascular disease risk prediction. We sought to investigate the use of a plasma proteomics-based approach in predicting different cardiovascular outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Among 51 859 UK Biobank participants (mean age, 56.7 years; 45.5% male) without cardiovascular disease and with proteomics measurements, we examined the primary composite outcome of fatal and nonfatal coronary heart disease, stroke, or heart failure (major adverse cardiovascular events), as well as additional secondary cardiovascular outcomes. An exposome-wide association study was conducted using relative protein concentrations, adjusted for a range of classic, demographic, and lifestyle risk factors. A prediction model using only age, sex, and protein markers (protein model) was developed using a least absolute shrinkage and selection operator-regularized approach (derivation: 80% of cohort) and validated using split-sample testing (20% of cohort). Their performance was assessed by comparing calibration, net reclassification index, and <i>c</i> statistic with the PREVENT (Predicting Risk of CVD Events) risk score.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Over a median 13.6 years of follow-up, 4857 participants experienced first major adverse cardiovascular events. After adjustment, the proteins most strongly associated with major adverse cardiovascular events included NT-proBNP (N-terminal pro B-type natriuretic peptide; hazard ratio [HR], 1.68 per SD increase), proADM (pro-adrenomedullin; HR, 1.60), GDF-15 (growth differentiation factor-15; HR, 1.47), WFDC2 (WAP four-disulfide core domain protein 2; HR, 1.46), and IGFBP4 (insulin-like growth factor-binding protein 4; HR, 1.41). In total, 222 separate proteins were predictors of all outcomes of interest in the protein model, and 86 were selected for the primary outcome specifically. In the validation cohort, compared with the PREVENT risk factor model, the protein model improved calibration, net reclassification (net reclassification index +0.09), and <i>c</i> statistic for major adverse cardiovascular events (+0.051). The protein model also improved the prediction of other outcomes, including ASCVD (<i>c</i> statistic +0.035), myocardial infarction (+0.023), stroke (+0.024), aortic stenosis (+0.015), heart failure (+0.060), abdominal aortic aneurysm (+0.024), and dementia (+0.068).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Measurement of targeted protein biomarkers produced superior prediction of aggregated and disaggregated cardiovascular events. This study represents an important proof of concept for the application of targeted proteomics in predicting a range of cardiovascular outcomes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39540306/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39540306</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070454>10.1161/CIRCULATIONAHA.124.070454</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39540306</guid>
<pubDate>Thu, 14 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Frederick K Ho</dc:creator>
<dc:creator>Patrick B Mark</dc:creator>
<dc:creator>Jennifer S Lees</dc:creator>
<dc:creator>Jill P Pell</dc:creator>
<dc:creator>Rona J Strawbridge</dc:creator>
<dc:creator>Dorien M Kimenai</dc:creator>
<dc:creator>Nicholas L Mills</dc:creator>
<dc:creator>Mark Woodward</dc:creator>
<dc:creator>John J V McMurray</dc:creator>
<dc:creator>Naveed Sattar</dc:creator>
<dc:creator>Paul Welsh</dc:creator>
<dc:date>2024-11-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>A Proteomics-Based Approach for Prediction of Different Cardiovascular Diseases and Dementia</dc:title>
<dc:identifier>pmid:39540306</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070454</dc:identifier>
</item>
<item>
<title>2024 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39540293/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>This is the eighth annual summary of the International Liaison Committee on Resuscitation International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations; a more comprehensive review was done in 2020. This latest summary addresses the most recent published resuscitation evidence reviewed by the International Liaison Committee on Resuscitation task force science experts. Members from 6 International Liaison Committee on...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Nov 14. doi: 10.1161/CIR.0000000000001288. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">This is the eighth annual summary of the International Liaison Committee on Resuscitation International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations; a more comprehensive review was done in 2020. This latest summary addresses the most recent published resuscitation evidence reviewed by the International Liaison Committee on Resuscitation task force science experts. Members from 6 International Liaison Committee on Resuscitation task forces have assessed, discussed, and debated the quality of the evidence, using Grading of Recommendations Assessment, Development, and Evaluation criteria, and their statements include consensus treatment recommendations. Insights into the deliberations of the task forces are provided in the Justification and Evidence-to-Decision Framework Highlights sections. In addition, the task forces list priority knowledge gaps for further research.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39540293/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39540293</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001288>10.1161/CIR.0000000000001288</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39540293</guid>
<pubDate>Thu, 14 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Robert Greif</dc:creator>
<dc:creator>Janet E Bray</dc:creator>
<dc:creator>Therese Djärv</dc:creator>
<dc:creator>Ian R Drennan</dc:creator>
<dc:creator>Helen G Liley</dc:creator>
<dc:creator>Kee-Chong Ng</dc:creator>
<dc:creator>Adam Cheng</dc:creator>
<dc:creator>Matthew J Douma</dc:creator>
<dc:creator>Barnaby R Scholefield</dc:creator>
<dc:creator>Michael Smyth</dc:creator>
<dc:creator>Gary Weiner</dc:creator>
<dc:creator>Cristian Abelairas-Gómez</dc:creator>
<dc:creator>Jason Acworth</dc:creator>
<dc:creator>Natalie Anderson</dc:creator>
<dc:creator>Dianne L Atkins</dc:creator>
<dc:creator>David C Berry</dc:creator>
<dc:creator>Farhan Bhanji</dc:creator>
<dc:creator>Bernd W Böttiger</dc:creator>
<dc:creator>Richard N Bradley</dc:creator>
<dc:creator>Jan Breckwoldt</dc:creator>
<dc:creator>Jestin N Carlson</dc:creator>
<dc:creator>Pascal Cassan</dc:creator>
<dc:creator>Wei-Tien Chang</dc:creator>
<dc:creator>Nathan P Charlton</dc:creator>
<dc:creator>Sung Phil Chung</dc:creator>
<dc:creator>Julie Considine</dc:creator>
<dc:creator>Andrea Cortegiani</dc:creator>
<dc:creator>Daniela T Costa-Nobre</dc:creator>
<dc:creator>Keith Couper</dc:creator>
<dc:creator>Thomaz Bittencourt Couto</dc:creator>
<dc:creator>Katie N Dainty</dc:creator>
<dc:creator>Vihara Dassanayake</dc:creator>
<dc:creator>Peter G Davis</dc:creator>
<dc:creator>Jennifer A Dawson</dc:creator>
<dc:creator>Allan R de Caen</dc:creator>
<dc:creator>Charles D Deakin</dc:creator>
<dc:creator>Guillaume Debaty</dc:creator>
<dc:creator>Jimena Del Castillo</dc:creator>
<dc:creator>Maya Dewan</dc:creator>
<dc:creator>Bridget Dicker</dc:creator>
<dc:creator>Jana Djakow</dc:creator>
<dc:creator>Aaron J Donoghue</dc:creator>
<dc:creator>Kathryn Eastwood</dc:creator>
<dc:creator>Walid El-Naggar</dc:creator>
<dc:creator>Raffo Escalante-Kanashiro</dc:creator>
<dc:creator>Jorge Fabres</dc:creator>
<dc:creator>Barbara Farquharson</dc:creator>
<dc:creator>Joe Fawke</dc:creator>
<dc:creator>Maria Fernanda de Almeida</dc:creator>
<dc:creator>Shannon M Fernando</dc:creator>
<dc:creator>Emer Finan</dc:creator>
<dc:creator>Judith Finn</dc:creator>
<dc:creator>Gustavo E Flores</dc:creator>
<dc:creator>Elizabeth E Foglia</dc:creator>
<dc:creator>Fredrik Folke</dc:creator>
<dc:creator>Craig A Goolsby</dc:creator>
<dc:creator>Asger Granfeldt</dc:creator>
<dc:creator>Anne-Marie Guerguerian</dc:creator>
<dc:creator>Ruth Guinsburg</dc:creator>
<dc:creator>Carolina Malta Hansen</dc:creator>
<dc:creator>Tetsuo Hatanaka</dc:creator>
<dc:creator>Karen G Hirsch</dc:creator>
<dc:creator>Mathias J Holmberg</dc:creator>
<dc:creator>Stuart Hooper</dc:creator>
<dc:creator>Amber V Hoover</dc:creator>
<dc:creator>Ming-Ju Hsieh</dc:creator>
<dc:creator>Takanari Ikeyama</dc:creator>
<dc:creator>Tetsuya Isayama</dc:creator>
<dc:creator>Nicholas J Johnson</dc:creator>
<dc:creator>Justin Josephsen</dc:creator>
<dc:creator>Anup Katheria</dc:creator>
<dc:creator>Mandira D Kawakami</dc:creator>
<dc:creator>Monica Kleinman</dc:creator>
<dc:creator>David Kloeck</dc:creator>
<dc:creator>Ying-Chih Ko</dc:creator>
<dc:creator>Peter Kudenchuk</dc:creator>
<dc:creator>Amy Kule</dc:creator>
<dc:creator>Hiroshi Kurosawa</dc:creator>
<dc:creator>Jorien Laermans</dc:creator>
<dc:creator>Anthony Lagina</dc:creator>
<dc:creator>Kasper G Lauridsen</dc:creator>
<dc:creator>Eric J Lavonas</dc:creator>
<dc:creator>Henry C Lee</dc:creator>
<dc:creator>Swee Han Lim</dc:creator>
<dc:creator>Yiqun Lin</dc:creator>
<dc:creator>Andrew S Lockey</dc:creator>
<dc:creator>Jesus Lopez-Herce</dc:creator>
<dc:creator>George Lukas</dc:creator>
<dc:creator>Finlay Macneil</dc:creator>
<dc:creator>Ian K Maconochie</dc:creator>
<dc:creator>John Madar</dc:creator>
<dc:creator>Abel Martinez-Mejas</dc:creator>
<dc:creator>Siobhan Masterson</dc:creator>
<dc:creator>Tasuku Matsuyama</dc:creator>
<dc:creator>Richard Mausling</dc:creator>
<dc:creator>Christopher J D McKinlay</dc:creator>
<dc:creator>Daniel Meyran</dc:creator>
<dc:creator>William Montgomery</dc:creator>
<dc:creator>Peter T Morley</dc:creator>
<dc:creator>Laurie J Morrison</dc:creator>
<dc:creator>Ari L Moskowitz</dc:creator>
<dc:creator>Michelle Myburgh</dc:creator>
<dc:creator>Sabine Nabecker</dc:creator>
<dc:creator>Vinay Nadkarni</dc:creator>
<dc:creator>Firdose Nakwa</dc:creator>
<dc:creator>Kevin J Nation</dc:creator>
<dc:creator>Ziad Nehme</dc:creator>
<dc:creator>Tonia Nicholson</dc:creator>
<dc:creator>Nikolaos Nikolaou</dc:creator>
<dc:creator>Chika Nishiyama</dc:creator>
<dc:creator>Tatsuya Norii</dc:creator>
<dc:creator>Gabrielle Nuthall</dc:creator>
<dc:creator>Shinichiro Ohshimo</dc:creator>
<dc:creator>Theresa Olasveengen</dc:creator>
<dc:creator>Alexander Olaussen</dc:creator>
<dc:creator>Gene Ong</dc:creator>
<dc:creator>Aaron Orkin</dc:creator>
<dc:creator>Michael J Parr</dc:creator>
<dc:creator>Gavin D Perkins</dc:creator>
<dc:creator>Helen Pocock</dc:creator>
<dc:creator>Yacov Rabi</dc:creator>
<dc:creator>Violetta Raffay</dc:creator>
<dc:creator>James Raitt</dc:creator>
<dc:creator>Tia Raymond</dc:creator>
<dc:creator>Giuseppe Ristagno</dc:creator>
<dc:creator>Antonio Rodriguez-Nunez</dc:creator>
<dc:creator>Joseph Rossano</dc:creator>
<dc:creator>Mario Rüdiger</dc:creator>
<dc:creator>Claudio Sandroni</dc:creator>
<dc:creator>Taylor L Sawyer</dc:creator>
<dc:creator>Stephen M Schexnayder</dc:creator>
<dc:creator>Georg Schmölzer</dc:creator>
<dc:creator>Sebastian Schnaubelt</dc:creator>
<dc:creator>Anna Lene Seidler</dc:creator>
<dc:creator>Federico Semeraro</dc:creator>
<dc:creator>Eunice M Singletary</dc:creator>
<dc:creator>Markus B Skrifvars</dc:creator>
<dc:creator>Christopher M Smith</dc:creator>
<dc:creator>Jasmeet Soar</dc:creator>
<dc:creator>Anne Lee Solevåg</dc:creator>
<dc:creator>Roger Soll</dc:creator>
<dc:creator>Willem Stassen</dc:creator>
<dc:creator>Takahiro Sugiura</dc:creator>
<dc:creator>Kaushila Thilakasiri</dc:creator>
<dc:creator>Janice Tijssen</dc:creator>
<dc:creator>Lokesh Kumar Tiwari</dc:creator>
<dc:creator>Alexis Topjian</dc:creator>
<dc:creator>Daniele Trevisanuto</dc:creator>
<dc:creator>Christian Vaillancourt</dc:creator>
<dc:creator>Michelle Welsford</dc:creator>
<dc:creator>Myra H Wyckoff</dc:creator>
<dc:creator>Chih-Wei Yang</dc:creator>
<dc:creator>Joyce Yeung</dc:creator>
<dc:creator>Carolyn M Zelop</dc:creator>
<dc:creator>David A Zideman</dc:creator>
<dc:creator>Jerry P Nolan</dc:creator>
<dc:creator>Katherine M Berg</dc:creator>
<dc:date>2024-11-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>2024 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces</dc:title>
<dc:identifier>pmid:39540293</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001288</dc:identifier>
</item>
<item>
<title>2024 American Heart Association and American Red Cross Guidelines for First Aid</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39540278/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>Codeveloped by the American Heart Association and the American Red Cross, these guidelines represent the first comprehensive update of first aid treatment recommendations since 2010. Incorporating the results of structured evidence reviews from the International Liaison Committee on Resuscitation, these guidelines cover first aid treatment for critical and common medical, traumatic, environmental, and toxicological conditions. This update emphasizes the continuous evolution of evidence...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Nov 14. doi: 10.1161/CIR.0000000000001281. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Codeveloped by the American Heart Association and the American Red Cross, these guidelines represent the first comprehensive update of first aid treatment recommendations since 2010. Incorporating the results of structured evidence reviews from the International Liaison Committee on Resuscitation, these guidelines cover first aid treatment for critical and common medical, traumatic, environmental, and toxicological conditions. This update emphasizes the continuous evolution of evidence evaluation and the necessity of adapting educational strategies to local needs and diverse community demographics. Existing guidelines remain relevant unless specifically updated in this publication. Key topics that are new, are substantially revised, or have significant new literature include opioid overdose, bleeding control, open chest wounds, spinal motion restriction, hypothermia, frostbite, presyncope, anaphylaxis, snakebite, oxygen administration, and the use of pulse oximetry in first aid, with the inclusion of pediatric-specific guidance as warranted.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39540278/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39540278</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001281>10.1161/CIR.0000000000001281</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39540278</guid>
<pubDate>Thu, 14 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Elizabeth K Hewett Brumberg</dc:creator>
<dc:creator>Matthew J Douma</dc:creator>
<dc:creator>Kostas Alibertis</dc:creator>
<dc:creator>Nathan P Charlton</dc:creator>
<dc:creator>Michael P Goldman</dc:creator>
<dc:creator>Katrina Harper-Kirksey</dc:creator>
<dc:creator>Seth C Hawkins</dc:creator>
<dc:creator>Amber V Hoover</dc:creator>
<dc:creator>Amy Kule</dc:creator>
<dc:creator>Stefan Leichtle</dc:creator>
<dc:creator>Sarah Frances McClure</dc:creator>
<dc:creator>George Sam Wang</dc:creator>
<dc:creator>Mark Whelchel</dc:creator>
<dc:creator>Lynn White</dc:creator>
<dc:creator>Eric J Lavonas</dc:creator>
<dc:creator>American Heart Association and American Red Cross</dc:creator>
<dc:date>2024-11-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>2024 American Heart Association and American Red Cross Guidelines for First Aid</dc:title>
<dc:identifier>pmid:39540278</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001281</dc:identifier>
</item>
<item>
<title>Unipolar Voltage Mapping to Predict Recovery of Left Ventricular Ejection Fraction in Patients With Recent-Onset Nonischemic Cardiomyopathy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39540275/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Left ventricular unipolar voltage abnormality is a potent predictor of LVEF recovery among patients recently diagnosed with nonischemic cardiomyopathy. Detailed left ventricular unipolar voltage mapping could therefore be used as a valuable prognostic tool in guiding treatment decisions.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Nov 14. doi: 10.1161/CIRCULATIONAHA.124.070501. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The ability to predict recovery of left ventricular ejection fraction (LVEF) in response to guideline-directed therapy among patients with nonischemic cardiomyopathy is desired. We sought to determine whether left ventricular endocardial unipolar voltage measured during invasive electroanatomic mapping could be used to predict LVEF recovery among those with recent-onset nonischemic cardiomyopathy.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We analyzed the left ventricular voltage maps of patients included in the eMAP trial (Electrogram-Guided Myocardial Advanced Phenotyping; NCT03293381), a prospective, nonrandomized, interventional trial conducted at 2 institutions between 2017 and 2020. Patients had recent-onset nonischemic cardiomyopathy defined by LVEF ≤45% and development of symptoms or signs of heart failure within the past 6 months. Detailed voltage maps of the left ventricular endocardium were generated using the CARTO electroanatomic mapping system. Abnormal unipolar amplitude was defined as &lt;8.27 mV. The primary end point was recovery of LVEF (Recovery) defined by a 1-year LVEF ≥50% or ≥45% with ≥10% increase from baseline.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Of the 29 enrolled patients (median age, 49 years [25th percentile, 39; 75th percentile, 59], 8 females [27.6%]), LVEF recovered in 13 (44.8%) by 1-year follow-up. The percentage of total endocardial surface area with unipolar voltage abnormality (AUA) was significantly lower among Recovery patients than No Recovery patients (18.2% [6.4, 22.4] versus 80.0% [29.5, 90.9]; <i>P</i>=0.004). Percent AUA was associated with lower likelihood of Recovery (odds ratio, 0.64 per 10% increase in AUA; 95% CI, 0.47-0.88; <i>P</i>=0.006). A 28% cutoff value for percent AUA was 92% sensitive and 75% specific with an area under the receiver operating characteristic curve of 0.81 (95% CI, 0.63-0.99; <i>P</i>=0.001) for predicting recovery versus no recovery. The majority of patients (12 of 13; 92.3%) with a percent AUA >;28% did not recover.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Left ventricular unipolar voltage abnormality is a potent predictor of LVEF recovery among patients recently diagnosed with nonischemic cardiomyopathy. Detailed left ventricular unipolar voltage mapping could therefore be used as a valuable prognostic tool in guiding treatment decisions.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39540275/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39540275</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070501>10.1161/CIRCULATIONAHA.124.070501</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39540275</guid>
<pubDate>Thu, 14 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Corentin Chaumont</dc:creator>
<dc:creator>Eliot Peyster</dc:creator>
<dc:creator>Konstantinos C Siontis</dc:creator>
<dc:creator>Daniele Muser</dc:creator>
<dc:creator>Suraj Kapa</dc:creator>
<dc:creator>Timothy M Markman</dc:creator>
<dc:creator>Rajeev K Pathak</dc:creator>
<dc:creator>Alireza Oraii</dc:creator>
<dc:creator>Oriol Rodriguez-Queralto</dc:creator>
<dc:creator>Frederic Anselme</dc:creator>
<dc:creator>Kenneth B Margulies</dc:creator>
<dc:creator>Francis E Marchlinski</dc:creator>
<dc:creator>David S Frankel</dc:creator>
<dc:date>2024-11-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Unipolar Voltage Mapping to Predict Recovery of Left Ventricular Ejection Fraction in Patients With Recent-Onset Nonischemic Cardiomyopathy</dc:title>
<dc:identifier>pmid:39540275</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070501</dc:identifier>
</item>
<item>
<title>Cardiodermatology: the heart of the connection between the skin and cardiovascular disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39537837/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>The skin and cardiovascular systems are connected in unique and meaningful ways, and many diseases conventionally considered as being limited to one organ system are more closely related than previously believed. Major cardiovascular diseases and phenomena such as infective endocarditis, congestive heart failure, Kawasaki disease and thromboembolism are associated with specific skin findings, and advances in genetics, immunology and clinical epidemiology show that inflammatory dermatological...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Nov 13. doi: 10.1038/s41569-024-01097-9. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The skin and cardiovascular systems are connected in unique and meaningful ways, and many diseases conventionally considered as being limited to one organ system are more closely related than previously believed. Major cardiovascular diseases and phenomena such as infective endocarditis, congestive heart failure, Kawasaki disease and thromboembolism are associated with specific skin findings, and advances in genetics, immunology and clinical epidemiology show that inflammatory dermatological diseases, such as psoriasis, have serious cardiovascular and cardiometabolic consequences. Additionally, commonly used cardiovascular therapies, such as antihypertensive medications, are associated with important cutaneous adverse effects, including photosensitivity, photocarcinogenesis and eczematous skin reactions. Moreover, systemic dermatological therapies, including retinoids, Janus kinase inhibitors and biologics, can alter the risk of cardiovascular and cardiometabolic diseases. In this Review on cardiodermatology, we provide interdisciplinary insights from dermatology and cardiology that will be of practical use to both cardiologists and generalists who manage cardiovascular and cardiometabolic diseases in patients with dermatological findings or histories. We discuss specific skin findings associated with cardiovascular diseases to aid in diagnosis; important cutaneous adverse effects of common cardiovascular therapies, for the purpose of treatment monitoring; and the effect of dermatological diseases and dermatological treatment on cardiovascular risk.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39537837/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39537837</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01097-9>10.1038/s41569-024-01097-9</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39537837</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Joel M Gelfand</dc:creator>
<dc:creator>William B Song</dc:creator>
<dc:creator>Sinéad M Langan</dc:creator>
<dc:creator>Michael S Garshick</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Cardiodermatology: the heart of the connection between the skin and cardiovascular disease</dc:title>
<dc:identifier>pmid:39537837</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01097-9</dc:identifier>
</item>
<item>
<title>Navigating Cardiovascular Employment Trends</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39537254/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Nov 19;84(21):2150-2153. doi: 10.1016/j.jacc.2024.10.063.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39537254/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39537254</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.10.063>10.1016/j.jacc.2024.10.063</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39537254</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Cathleen Biga</dc:creator>
<dc:creator>Geoffrey A Rose</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Navigating Cardiovascular Employment Trends</dc:title>
<dc:identifier>pmid:39537254</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.10.063</dc:identifier>
</item>
<item>
<title>A Bold New Era of Collaboration: JACC and JACC Clinical Electrophysiology Unite</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39537253/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Nov 19;84(21):2148-2149. doi: 10.1016/j.jacc.2024.10.066.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39537253/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39537253</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.10.066>10.1016/j.jacc.2024.10.066</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39537253</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Kalyanam Shivkumar</dc:creator>
<dc:creator>Harlan M Krumholz</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>A Bold New Era of Collaboration: JACC and JACC Clinical Electrophysiology Unite</dc:title>
<dc:identifier>pmid:39537253</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.10.066</dc:identifier>
</item>
<item>
<title>Ten Years of Leadless Cardiac Pacing</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39537252/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>Leadless pacemakers (LPs) are self-contained pacemakers implanted inside the heart, providing a clinical strategy of pacing without pacemaker leads or a subcutaneous pocket. From an experimental therapy first used clinically in 2012, a decade later this technology is an established treatment option. Because of technologic advances and growing evidence, LPs are increasingly being used. Herein, the experience gained from a decade of leadless pacing is reviewed. We cover the safety and efficacy of...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Nov 19;84(21):2131-2147. doi: 10.1016/j.jacc.2024.08.077.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Leadless pacemakers (LPs) are self-contained pacemakers implanted inside the heart, providing a clinical strategy of pacing without pacemaker leads or a subcutaneous pocket. From an experimental therapy first used clinically in 2012, a decade later this technology is an established treatment option. Because of technologic advances and growing evidence, LPs are increasingly being used. Herein, the experience gained from a decade of leadless pacing is reviewed. We cover the safety and efficacy of single-chamber LPs, including comparisons with transvenous pacemakers and various models, and the initial clinical results of the first dual-chamber LP system. Furthermore, evidence and considerations regarding the optimal replacement strategy will be covered. Finally, we discuss future device developments that may broaden indications, such as LPs communicating with subcutaneous implantable cardiac defibrillators and energy-harvesting LPs.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39537252/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39537252</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.077>10.1016/j.jacc.2024.08.077</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39537252</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Karel T N Breeman</dc:creator>
<dc:creator>Fleur V Y Tjong</dc:creator>
<dc:creator>Marc A Miller</dc:creator>
<dc:creator>Petr Neuzil</dc:creator>
<dc:creator>Srinivas Dukkipati</dc:creator>
<dc:creator>Reinoud E Knops</dc:creator>
<dc:creator>Vivek Y Reddy</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Ten Years of Leadless Cardiac Pacing</dc:title>
<dc:identifier>pmid:39537252</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.077</dc:identifier>
</item>
<item>
<title>The Rebirth of Intraoperative Electrophysiological Mapping for Complex Congenital Heart Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39537251/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Nov 19;84(21):2113-2115. doi: 10.1016/j.jacc.2024.08.078.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39537251/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39537251</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.08.078>10.1016/j.jacc.2024.08.078</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39537251</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Jeremy P Moore</dc:creator>
<dc:creator>Kalyanam Shivkumar</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>The Rebirth of Intraoperative Electrophysiological Mapping for Complex Congenital Heart Disease</dc:title>
<dc:identifier>pmid:39537251</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.08.078</dc:identifier>
</item>
<item>
<title>Intraoperative Conduction Mapping to Reduce Postoperative Atrioventricular Block in Complex Congenital Heart Disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39537250/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Intraoperative HB mapping can be performed safely and is associated with significantly reduced postoperative AVB/PM in select populations undergoing complex biventricular repair, including heterotaxy syndrome and non-L-malposed great arteries. Nonetheless, certain subgroups remain at risk for AVB/PM, showing the need for further improvements to current intraoperative HB mapping technology and techniques.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Nov 19;84(21):2102-2112. doi: 10.1016/j.jacc.2024.07.054.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Postoperative atrioventricular block requiring pacemaker (AVB/PM) complicates 14% to 25% of biventricular repair operations for complex congenital heart disease (CHD) and in those with heterotaxy syndrome.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: This study aimed to evaluate if intraoperative His bundle (HB) mapping during complex biventricular CHD repair can be performed safely and reduce postoperative AVB/PM.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: HB mapping was performed using a commercially available multielectrode grid catheter in patients with complex CHD undergoing biventricular repair between 2019 and 2022 compared with an unmapped cohort. The primary outcome was postoperative AVB/PM.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: One hundred forty-nine patients underwent HB mapping compared to 201 unmapped controls. The median age of mapped patients was 1.9 years (Q1-Q3: 0.9-3.9 years). Heterotaxy syndrome was present in 31% (n = 46 of 149), ventricular septal defect in 95% (n = 142 of 149), and prior single ventricle palliation in 68% (n = 89 of 149). The HB was identified in 97% (n = 144 of 149) of cases. The median mapping time was 6 minutes. No episodes of intraoperative systemic air embolism occurred. Postoperative AVB/PM frequency was significantly reduced in mapped patients with heterotaxy (2% [n = 1 of 46] vs 16% [n = 11 of 67]; P = 0.026) and in patients without L-malposed great arteries (3% [n = 3 of 88] vs 11% [n = 15 of 134]; P = 0.045).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Intraoperative HB mapping can be performed safely and is associated with significantly reduced postoperative AVB/PM in select populations undergoing complex biventricular repair, including heterotaxy syndrome and non-L-malposed great arteries. Nonetheless, certain subgroups remain at risk for AVB/PM, showing the need for further improvements to current intraoperative HB mapping technology and techniques.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39537250/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39537250</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.07.054>10.1016/j.jacc.2024.07.054</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39537250</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Edward T O'Leary</dc:creator>
<dc:creator>Eric N Feins</dc:creator>
<dc:creator>Jocelyn Davee</dc:creator>
<dc:creator>Christopher W Baird</dc:creator>
<dc:creator>Rebecca Beroukhim</dc:creator>
<dc:creator>Pedro J Del Nido</dc:creator>
<dc:creator>Audrey Dionne</dc:creator>
<dc:creator>Kimberlee Gauvreau</dc:creator>
<dc:creator>David M Hoganson</dc:creator>
<dc:creator>John K Triedman</dc:creator>
<dc:creator>Edward P Walsh</dc:creator>
<dc:creator>Meena Nathan</dc:creator>
<dc:creator>Sitaram M Emani</dc:creator>
<dc:creator>Elizabeth S DeWitt</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Intraoperative Conduction Mapping to Reduce Postoperative Atrioventricular Block in Complex Congenital Heart Disease</dc:title>
<dc:identifier>pmid:39537250</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.07.054</dc:identifier>
</item>
<item>
<title>Ischaemic heart disease: focus on sex-related differences and novel therapeutic targets</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39537149/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Nov 14;45(43):4553-4557. doi: 10.1093/eurheartj/ehae769.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39537149/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39537149</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae769>10.1093/eurheartj/ehae769</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39537149</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Ischaemic heart disease: focus on sex-related differences and novel therapeutic targets</dc:title>
<dc:identifier>pmid:39537149</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae769</dc:identifier>
</item>
<item>
<title>A Zea genus-specific micropeptide controls kernel dehydration in maize</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39536747/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>Kernel dehydration rate (KDR) is a crucial production trait that affects mechanized harvesting and kernel quality in maize; however, the underlying mechanisms remain unclear. Here, we identified a quantitative trait locus (QTL), qKDR1, as a non-coding sequence that regulates the expression of qKDR1 REGULATED PEPTIDE GENE (RPG). RPG encodes a 31 amino acid micropeptide, microRPG1, which controls KDR by precisely modulating the expression of two genes, ZmETHYLENE-INSENSITIVE3-like 1 and 3, in the...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Nov 7:S0092-8674(24)01212-1. doi: 10.1016/j.cell.2024.10.030. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Kernel dehydration rate (KDR) is a crucial production trait that affects mechanized harvesting and kernel quality in maize; however, the underlying mechanisms remain unclear. Here, we identified a quantitative trait locus (QTL), qKDR1, as a non-coding sequence that regulates the expression of qKDR1 REGULATED PEPTIDE GENE (RPG). RPG encodes a 31 amino acid micropeptide, microRPG1, which controls KDR by precisely modulating the expression of two genes, ZmETHYLENE-INSENSITIVE3-like 1 and 3, in the ethylene signaling pathway in the kernels after filling. microRPG1 is a Zea genus-specific micropeptide and originated de novo from a non-coding sequence. Knockouts of microRPG1 result in faster KDR in maize. By contrast, overexpression or exogenous application of the micropeptide shows the opposite effect both in maize and Arabidopsis. Our findings reveal the molecular mechanism of microRPG1 in kernel dehydration and provide an important tool for future crop breeding.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39536747/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39536747</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.10.030>10.1016/j.cell.2024.10.030</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39536747</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Yanhui Yu</dc:creator>
<dc:creator>Wenqiang Li</dc:creator>
<dc:creator>Yuanfang Liu</dc:creator>
<dc:creator>Yanjun Liu</dc:creator>
<dc:creator>Qinzhi Zhang</dc:creator>
<dc:creator>Yidan Ouyang</dc:creator>
<dc:creator>Wenya Ding</dc:creator>
<dc:creator>Yu Xue</dc:creator>
<dc:creator>Yilin Zou</dc:creator>
<dc:creator>Junjun Yan</dc:creator>
<dc:creator>Anqiang Jia</dc:creator>
<dc:creator>Jiali Yan</dc:creator>
<dc:creator>Xinfei Hao</dc:creator>
<dc:creator>Yujie Gou</dc:creator>
<dc:creator>Zhaowei Zhai</dc:creator>
<dc:creator>Longyu Liu</dc:creator>
<dc:creator>Yang Zheng</dc:creator>
<dc:creator>Bao Zhang</dc:creator>
<dc:creator>Jieting Xu</dc:creator>
<dc:creator>Ning Yang</dc:creator>
<dc:creator>Yingjie Xiao</dc:creator>
<dc:creator>Lin Zhuo</dc:creator>
<dc:creator>Zhibing Lai</dc:creator>
<dc:creator>Ping Yin</dc:creator>
<dc:creator>Hai-Jun Liu</dc:creator>
<dc:creator>Alisdair R Fernie</dc:creator>
<dc:creator>David Jackson</dc:creator>
<dc:creator>Jianbing Yan</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A Zea genus-specific micropeptide controls kernel dehydration in maize</dc:title>
<dc:identifier>pmid:39536747</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.10.030</dc:identifier>
</item>
<item>
<title>A β-hydroxybutyrate shunt pathway generates anti-obesity ketone metabolites</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39536746/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>β-Hydroxybutyrate (BHB) is an abundant ketone body. To date, all known pathways of BHB metabolism involve the interconversion of BHB and primary energy intermediates. Here, we identify a previously undescribed BHB secondary metabolic pathway via CNDP2-dependent enzymatic conjugation of BHB and free amino acids. This BHB shunt pathway generates a family of anti-obesity ketone metabolites, the BHB-amino acids. Genetic ablation of CNDP2 in mice eliminates tissue amino acid BHB-ylation activity and...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Nov 7:S0092-8674(24)01214-5. doi: 10.1016/j.cell.2024.10.032. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">β-Hydroxybutyrate (BHB) is an abundant ketone body. To date, all known pathways of BHB metabolism involve the interconversion of BHB and primary energy intermediates. Here, we identify a previously undescribed BHB secondary metabolic pathway via CNDP2-dependent enzymatic conjugation of BHB and free amino acids. This BHB shunt pathway generates a family of anti-obesity ketone metabolites, the BHB-amino acids. Genetic ablation of CNDP2 in mice eliminates tissue amino acid BHB-ylation activity and reduces BHB-amino acid levels. The most abundant BHB-amino acid, BHB-Phe, is a ketosis-inducible congener of Lac-Phe that activates hypothalamic and brainstem neurons and suppresses feeding. Conversely, CNDP2-KO mice exhibit increased food intake and body weight following exogenous ketone ester supplementation or a ketogenic diet. CNDP2-dependent amino acid BHB-ylation and BHB-amino acid metabolites are also conserved in humans. Therefore, enzymatic amino acid BHB-ylation defines a ketone shunt pathway and bioactive ketone metabolites linked to energy balance.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39536746/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39536746</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.10.032>10.1016/j.cell.2024.10.032</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39536746</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Maria Dolores Moya-Garzon</dc:creator>
<dc:creator>Mengjie Wang</dc:creator>
<dc:creator>Veronica L Li</dc:creator>
<dc:creator>Xuchao Lyu</dc:creator>
<dc:creator>Wei Wei</dc:creator>
<dc:creator>Alan Sheng-Hwa Tung</dc:creator>
<dc:creator>Steffen H Raun</dc:creator>
<dc:creator>Meng Zhao</dc:creator>
<dc:creator>Laetitia Coassolo</dc:creator>
<dc:creator>Hashim Islam</dc:creator>
<dc:creator>Barbara Oliveira</dc:creator>
<dc:creator>Yuqin Dai</dc:creator>
<dc:creator>Jan Spaas</dc:creator>
<dc:creator>Antonio Delgado-Gonzalez</dc:creator>
<dc:creator>Kenyi Donoso</dc:creator>
<dc:creator>Aurora Alvarez-Buylla</dc:creator>
<dc:creator>Francisco Franco-Montalban</dc:creator>
<dc:creator>Anudari Letian</dc:creator>
<dc:creator>Catherine P Ward</dc:creator>
<dc:creator>Lichao Liu</dc:creator>
<dc:creator>Katrin J Svensson</dc:creator>
<dc:creator>Emily L Goldberg</dc:creator>
<dc:creator>Christopher D Gardner</dc:creator>
<dc:creator>Jonathan P Little</dc:creator>
<dc:creator>Steven M Banik</dc:creator>
<dc:creator>Yong Xu</dc:creator>
<dc:creator>Jonathan Z Long</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A β-hydroxybutyrate shunt pathway generates anti-obesity ketone metabolites</dc:title>
<dc:identifier>pmid:39536746</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.10.032</dc:identifier>
</item>
<item>
<title>Decoding transcriptional identity in developing human sensory neurons and organoid modeling</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39536745/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>Dorsal root ganglia (DRGs) play a crucial role in processing sensory information, making it essential to understand their development. Here, we construct a single-cell spatiotemporal transcriptomic atlas of human embryonic DRG. This atlas reveals the diversity of cell types and highlights the extrinsic signaling cascades and intrinsic regulatory hierarchies that guide cell fate decisions, including neuronal/glial lineage restriction, sensory neuron differentiation and specification, and the...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Nov 4:S0092-8674(24)01205-4. doi: 10.1016/j.cell.2024.10.023. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Dorsal root ganglia (DRGs) play a crucial role in processing sensory information, making it essential to understand their development. Here, we construct a single-cell spatiotemporal transcriptomic atlas of human embryonic DRG. This atlas reveals the diversity of cell types and highlights the extrinsic signaling cascades and intrinsic regulatory hierarchies that guide cell fate decisions, including neuronal/glial lineage restriction, sensory neuron differentiation and specification, and the formation of neuron-satellite glial cell (SGC) units. Additionally, we identify a human-enriched NTRK3<sup>+</sup>/DCC<sup>+</sup> nociceptor subtype, which is involved in multimodal nociceptive processing. Mimicking the programmed activation of signaling pathways in vivo, we successfully establish functional human DRG organoids and underscore the critical roles of transcriptional regulators in the fate commitment of unspecialized sensory neurons (uSNs). Overall, our research elucidates the multilevel signaling pathways and transcription factor (TF) regulatory hierarchies that underpin the diversity of somatosensory neurons, emphasizing the phenotypic distinctions in human nociceptor subtypes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39536745/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39536745</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.10.023>10.1016/j.cell.2024.10.023</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39536745</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Tian Lu</dc:creator>
<dc:creator>Mengdi Wang</dc:creator>
<dc:creator>Wei Zhou</dc:creator>
<dc:creator>Qi Ni</dc:creator>
<dc:creator>Yuanlei Yue</dc:creator>
<dc:creator>Wei Wang</dc:creator>
<dc:creator>Yingchao Shi</dc:creator>
<dc:creator>Zeyuan Liu</dc:creator>
<dc:creator>Changlin Li</dc:creator>
<dc:creator>Bei Hong</dc:creator>
<dc:creator>Xin Zhou</dc:creator>
<dc:creator>Suijuan Zhong</dc:creator>
<dc:creator>Kaikai Wang</dc:creator>
<dc:creator>Bo Zeng</dc:creator>
<dc:creator>Jun Zhang</dc:creator>
<dc:creator>Wei Wang</dc:creator>
<dc:creator>Xu Zhang</dc:creator>
<dc:creator>Qian Wu</dc:creator>
<dc:creator>Xiaoqun Wang</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Decoding transcriptional identity in developing human sensory neurons and organoid modeling</dc:title>
<dc:identifier>pmid:39536745</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.10.023</dc:identifier>
</item>
<item>
<title>Clonal Hematopoiesis of Indeterminate Potential</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39535811/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 Nov 13. doi: 10.1001/jamacardio.2024.3773. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39535811/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39535811</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.3773>10.1001/jamacardio.2024.3773</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39535811</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Peter Libby</dc:creator>
<dc:creator>Ohad Oren</dc:creator>
<dc:creator>Aeron M Small</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Clonal Hematopoiesis of Indeterminate Potential</dc:title>
<dc:identifier>pmid:39535811</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.3773</dc:identifier>
</item>
<item>
<title>Bidirectional Risk Modulator and Modifier Variant of Dilated and Hypertrophic Cardiomyopathy in BAG3</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39535783/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241115111347&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: BAG3 C151R was identified as a bidirectional modulator of risk along the DCM-HCM spectrum, as well as an important genetic modifier variant in TTN-mediated DCM. This work expands on the understanding of the etiology and penetrance of DCM, suggesting that BAG3 C151R is an important genetic modifier variant contributing to the variable expressivity of DCM, warranting further exploration of its mechanisms and of genetic modifiers in DCM more broadly.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2024 Nov 13:e243547. doi: 10.1001/jamacardio.2024.3547. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: The genetic factors that modulate the reduced penetrance and variable expressivity of heritable dilated cardiomyopathy (DCM) are largely unknown. BAG3 genetic variants have been implicated in both DCM and hypertrophic cardiomyopathy (HCM), nominating BAG3 as a gene that harbors potential modifier variants in DCM.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To interrogate the clinical traits and diseases associated with BAG3 coding variation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: This was a cross-sectional study in the Penn Medicine BioBank (PMBB) enrolling patients of the University of Pennsylvania Health System's clinical practice sites from 2014 to 2023. Whole-exome sequencing (WES) was linked to electronic health record (EHR) data to associate BAG3 coding variants with EHR phenotypes. This was a health care population-based study including individuals of European and African genetic ancestry in the PMBB with WES linked to EHR phenotypes, with replication studies in BioVU, UK Biobank, MyCode, and DCM Precision Medicine Study.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">EXPOSURES: Carrier status for BAG3 coding variants.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: Association of BAG3 coding variation with clinical diagnoses, echocardiographic traits, and longitudinal outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: In PMBB (n = 43 731; median [IQR] age, 65 [50-76] years; 21 907 female [50.1%]), among 30 324 European and 11 198 African individuals, the common C151R variant was associated with decreased risk for DCM (odds ratio [OR], 0.85; 95% CI, 0.78-0.92) and simultaneous increased risk for HCM (OR, 1.59; 95% CI, 1.25-2.02), which was confirmed in the replication cohorts. C151R carriers exhibited improved longitudinal outcomes compared with noncarriers as assessed by age at death (hazard ratio [HR], 0.85; 95% CI, 0.74-0.96; median [IQR] age, 71.8 [63.1-80.7] in carriers and 70.3 [61.6-79.2] in noncarriers) and heart transplant (HR, 0.81; 95% CI, 0.66-0.99; median [IQR] age, 56.7 [46.1-63.1] in carriers and 55.6 [45.2-62.9] in noncarriers). C151R was associated with reduced risk of DCM (OR, 0.42; 95% CI, 0.24-0.74) and heart failure (OR, 0.27; 95% CI, 0.14-0.50) among individuals harboring truncating TTN variants in exons with high cardiac expression (n = 358).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: BAG3 C151R was identified as a bidirectional modulator of risk along the DCM-HCM spectrum, as well as an important genetic modifier variant in TTN-mediated DCM. This work expands on the understanding of the etiology and penetrance of DCM, suggesting that BAG3 C151R is an important genetic modifier variant contributing to the variable expressivity of DCM, warranting further exploration of its mechanisms and of genetic modifiers in DCM more broadly.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39535783/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">39535783</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11561727/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241115111347&v=2.18.0.post9+e462414">PMC11561727</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.3547>10.1001/jamacardio.2024.3547</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39535783</guid>
<pubDate>Wed, 13 Nov 2024 06:00:00 -0500</pubDate>
<dc:creator>Joseph Park</dc:creator>
<dc:creator>Michael G Levin</dc:creator>
<dc:creator>David Zhang</dc:creator>
<dc:creator>Nosheen Reza</dc:creator>
<dc:creator>Jonathan O Mead</dc:creator>
<dc:creator>Eric D Carruth</dc:creator>
<dc:creator>Melissa A Kelly</dc:creator>
<dc:creator>Alex Winters</dc:creator>
<dc:creator>Colleen M Kripke</dc:creator>
<dc:creator>Renae L Judy</dc:creator>
<dc:creator>Scott M Damrauer</dc:creator>
<dc:creator>Anjali T Owens</dc:creator>
<dc:creator>Lisa Bastarache</dc:creator>
<dc:creator>Anurag Verma</dc:creator>
<dc:creator>Daniel D Kinnamon</dc:creator>
<dc:creator>Ray E Hershberger</dc:creator>
<dc:creator>Marylyn D Ritchie</dc:creator>
<dc:creator>Daniel J Rader</dc:creator>
<dc:date>2024-11-13</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Bidirectional Risk Modulator and Modifier Variant of Dilated and Hypertrophic Cardiomyopathy in BAG3</dc:title>
<dc:identifier>pmid:39535783</dc:identifier>
<dc:identifier>pmc:PMC11561727</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.3547</dc:identifier>
</item>





























</channel>
</rss>